Probiotic Species in the Modulation of Gut Microbiota: An Overview

BioMed Research International

Volumn 2018, Issue , 2018, Pages

  Azad, Md Abul Kalam ^a,b   Sarker, Manobendro ^c   Li, Tiejun ^a   Yin, Jie ^a,b  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c STATE UNIVERSITY OF BANGLADESH   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT; SHORT CHAIN FATTY ACID;

BIFIDOBACTERIUM; ENTEROCOCCUS; ESCHERICHIA COLI; HUMAN; INTESTINE FLORA; LACTOBACILLUS; NONHUMAN; REVIEW; SACCHAROMYCES; ANIMAL; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; MICROFLORA;

ANIMALS; BIFIDOBACTERIUM; GASTROINTESTINAL MICROBIOME; HUMANS; LACTOBACILLUS; MICROBIOTA; PROBIOTICS; SACCHAROMYCES;

EID: 85047653684     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2018/9478630     Document Type: Review

References (83)

1. G. la Fata, P. Weber, and M. H. Mohajeri, "Probiotics and the Gut Immune System: Indirect Regulation, " Probiotics and Antimicrobial Proteins, pp. 1-11, 2017.
2. A. C. Brown and A. Valiere, "Probiotics and medical nutrition therapy, "Nutrition inClinical Care, vol. 7, no. 2, pp. 56-68, 2004.
3. E. Metchnikoff, "The prolongation of life: optimistic studies, " C. P. Mitchell, Ed., GP Putnam's Sons, New York, NY, USA, 1908.
4. F. Vergin, "Anti-und Probiotica, " Hipokrates, vol. 25, pp. 116-119, 1954.
5. D. M. Lilly and R. H. Stillwell, "Probiotics: growth-promoting factors produced bymicroorganisms, " Science, vol. 147, no. 3659, pp. 747-748, 1965.
6. Food and Agriculture Organization (FAO), Guidelines for the Evaluation of Probiotics in Food; Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food; FAO: London, ON, Canada, 2002.
7. C. Hill, F. Guarner, G. Reid et al., "Expert consensus document: the International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic, " Nature Reviews Gastroenterology & Hepatology, vol. 11, no. 8, pp. 506-514, 2014.
8. P. Markowiak and K. Ślizewska, "Effects of probiotics, prebiotics, and synbiotics on human health, " Nutrients, vol. 9, no. 9, article no. 1021, 2017.
9. M. He and B. Shi, "Gut microbiota as a potential target ofmetabolic syndrome: The role of probiotics and prebiotics, " Cell & Bioscience, vol. 7, no. 1, article no. 54, 2017.
10. M.-J. Butel, "Probiotics, gut microbiota and health, "Médecine et Maladies Infectieuses, vol. 44, no. 1, pp. 1-8, 2014.
11. H. Kitazawa, S. Alvarez, A. Suvorov, V. Melnikov, J. Villena, and B. Sánchez, "Recent advances and future perspective in microbiota and probiotics, " BioMed Research International, vol. 2015, Article ID 275631, 2015.
12. S. Lebeer, J. Vanderleyden, and S. C. J. de Keersmaecker, "Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens, " Nature Reviews Microbiology, vol. 8, no. 3, pp. 171-184, 2010.
13. P. A. Bron, P. van Baarlen, and M. Kleerebezem, "Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa, " Nature Reviews Microbiology, vol. 10, no. 1, pp. 66-78, 2012.
14. H. Kitazawa, J. Villena, and A. Susana, Probiotics: Immunobiotics and Immunogenics, CRC Press, 2013.
15. J. S. Park et al., "Lactobacillus acidophilus improves intestinal inflammation in an acute colitis mouse model by regulation of Th17 and Treg cell balance and fibrosis development, " Journal of Medicinal Food, 2018.
16. K. Khazaie, M. Zadeh, M.W. Khan et al., "Abating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acid, " Proceedings of the National Acadamy of Sciences of the United States of America, vol. 109, no. 26, pp. 10462-10467, 2012.
17. L. Chen, Y. Zou, J. Peng et al., "Lactobacillus acidophilus suppresses colitis-associated activation of the IL-23/Th17 axis, " Journal of Immunology Research, vol. 2015, Article ID 909514, 2015.
18. L.-L. Chen, Y.-Y. Zou, F.-G. Lu, F.-J. Li, and G.-H. Lian, "Efficacy profiles for different concentrations of Lactobacillus acidophilus in experimental colitis, " World Journal of Gastroenterology, vol. 19, no. 32, pp. 5347-5356, 2013.
19. M. Lenoir, S. del Carmen, N. G. Cortes-Perez et al., "Lactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancer, " Journal of Gastroenterology, vol. 51, no. 9, pp. 862-873, 2016.
20. E. Jacouton, F. Chain, H. Sokol, P. Langella, and L. G. Bermúdez- Humarán, "Probiotic strain Lactobacillus casei BL23 prevents colitis-associated colorectal cancer, " Frontiers in Immunology, vol. 8, article no. 1553, 2017.
21. H.-S. Lye, T. Kato, W.-Y. Low et al., "Lactobacillus fermentum FTDC 8312 combats hypercholesterolemia via alteration of gut microbiota, " Journal of Biotechnology, vol. 262, pp. 75-83, 2017.
22. N. Nakamoto, T. Amiya, R. Aoki et al., "Commensal Lactobacillus Controls Immune Tolerance during Acute Liver Injury in Mice, " Cell Reports, vol. 21, no. 5, pp. 1215-1226, 2017.
23. J. Zhao et al., "Lactobacillus plantarum CCFM10 alleviating oxidative stress and restoring the gut microbiota in d-galactoseinduced aging mice, " Food & Function, 2018.
24. L. Xue, J. He, N. Gao et al., "Probioticsmay delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia, " Scientific Reports, vol. 7, Article ID 45176, 2017.
25. R. A. Bagarolli, N. Tobar, A. G. Oliveira et al., "Probioticsmodulate gut microbiota and improve insulin sensitivity in DIO mice, " The Journal of Nutritional Biochemistry, vol. 50, pp. 16- 25, 2017.
26. B. Sánchez, I. González-Rodríguez, S. Arboleya et al., "The effects of bifidobacterium breve on immune mediators and proteome of ht29 cells monolayers, " BioMed Research International, vol. 2015, Article ID 479140, 2015.
27. T. Secher, S. Kassem, M. Benamar et al., "Oral administration of the probiotic strain Escherichia coli Nissle 1917 reduces susceptibility to neuroinflammation and repairs experimental autoimmune encephalomyelitis-induced intestinal barrier dysfunction, " Frontiers in Immunology, vol. 8, article no. 1096, 2017.
28. L. Yu, X.-K. Zhao, M.-L. Cheng et al., "Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates DGalactosamine- Induced Liver Injury, " Scientific Reports, vol. 7, no. 1, article no. 1359, 2017.
29. A. Everard, S. Matamoros, L. Geurts, N.M. Delzenne, and P. D. Cani, "Saccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db/db mice, " mBio, vol. 5, no. 3, 2014.
30. R. Daillère, M. Vétizou, N. Waldschmitt et al., "Enterococcus hirae and Barnesiella intestinihominis FacilitateCyclophosphamide- Induced Therapeutic Immunomodulatory Effects, " Immunity, vol. 45, no. 4, pp. 931-943, 2016.
31. J. Lederberg and A. T. McCray, "Ome sweet omics-a genealogical treasury of words, " The Scientist, vol. 15, no. 7, 8 pages, 2001.
32. R. Sender, S. Fuchs, and R. Milo, "Revised Estimates for the Number of Human and Bacteria Cells in the Body, " PLoS Biology, vol. 14, no. 8, Article IDe1002533, 2016.
33. F. Bäckhed, H. Ding, T. Wang et al., "The gut microbiota as an environmental factor that regulates fat storage, " Proceedings of theNational Acadamy of Sciences of theUnited States of America, vol. 101, no. 44, pp. 15718-15723, 2004.
34. J. G. LeBlanc, C. Milani, G. S. de Giori, F. Sesma, D. van Sinderen, and M. Ventura, "Bacteria as vitamin suppliers to their host: A gut microbiota perspective, " Current Opinion in Biotechnology, vol. 24, no. 2, pp. 160-168, 2013.
35. K. Endt, B. Stecher, S. Chaffron et al., "Themicrobiotamediates pathogen clearance from the gut lumen after non-typhoidal salmonella diarrhea, " PLoS Pathogens, vol. 6, no. 9, Article ID e01097, 2010.
36. J. L. Round and S. K. Mazmanian, "The gut microbiota shapes intestinal immune responses during health and disease, " Nature Reviews Immunology, vol. 9, no. 5, pp. 313-323, 2009.
37. S. M. Collins, M. Surette, and P. Bercik, "The interplay between the intestinal microbiota and the brain, " Nature Reviews Microbiology, vol. 10, no. 11, pp. 735-742, 2012.
38. P. Bin, S. Liu, S. Chen et al., "The effect of aspartate supplementation on the microbial composition and innate immunity on mice, " Amino Acids, vol. 49, no. 12, pp. 2045-2051, 2017.
39. Q. Feng, S. Liang, H. Jia et al., "Gut microbiome development along the colorectal adenoma-carcinoma sequence, " Nature Communications, vol. 6, 2015.
40. N. S. Barteneva, Y. Baiken, E. Fasler-Kan et al., "Extracellular vesicles in gastrointestinal cancer in conjunction with microbiota: On the border of Kingdoms, " Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol. 1868, no. 2, pp. 372-393, 2017.
41. M. J. Saez-Lara, C. Gomez-Llorente, J. Plaza-Diaz, and A. Gil, "The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials, " BioMed Research International, vol. 2015, Article ID 505878, 15 pages, 2015.
42. V. Nobili, L. Putignani, A. Mosca et al., "Bifidobacteria and lactobacilli in the gut microbiome of children with non-alcoholic fatty liver disease: which strains act as health players?" Archives of Medical Science, vol. 14, no. 1, pp. 81-87, 2018.
43. F. Li, K. Duan, C. Wang, C. McClain, and W. Feng, "Probiotics and alcoholic liver disease: treatment and potential mechanisms, " Gastroenterology Research and Practice, vol. 2016, pp. 1- 11, 2016.
44. M. J. Claesson, I. B. Jeffery, S. Conde et al., "Gut microbiota composition correlates with diet and health in the elderly, " Nature, vol. 488, no. 7410, pp. 178-184, 2012.
45. Y.-J. Zhang, S. Li, R.-Y. Gan, T. Zhou, D.-P. Xu, and H.-B. Li, "Impacts of gut bacteria on human health and diseases, " International Journal of Molecular Sciences, vol. 16, no. 4, pp. 7493- 7519, 2015.
46. W. H. W. Tang and S. L. Hazen, "The contributory role of gut microbiota in cardiovascular disease, " The Journal of Clinical Investigation, vol. 124, no. 10, pp. 4204-4211, 2014.
47. F. Z. Marques, E. Nelson, P.-Y. Chu et al., "High Fibre Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in DOCA-Salt Hypertensive Mice, " Circulation, 2017.
48. J. A. Foster and K.-A. McVey Neufeld, "Gut-brain axis: How the microbiome influences anxiety and depression, " Trends in Neurosciences, vol. 36, no. 5, pp. 305-312, 2013.
49. Y. Liang, S. Liang, Y. Zhang et al., "Oral Administration of compound probiotics ameliorates HFD-induced gut microbe dysbiosis and chronic metabolic inflammation via the G proteincoupled receptor 43 in non-alcoholic fatty liver disease rats, " Probiotics and Antimicrobial Proteins, 2018.
50. R. Gu, Z. Yang, X. Chen et al., "The effect of Lactobacillus rhamnosus hsryfm1301 on the intestinal microbiota of a hyperlipidemic ratmodel, " BMC Complementary and AlternativeMedicine, vol. 14, p. 386, 2014.
51. R.V. Bubnov, L. P. Babenko, L. M. Lazarenko et al., "Comparative study of probiotic effects of Lactobacillus and Bifidobacteria strains on cholesterol levels, liver morphology and the gut microbiota in obese mice, " EPMA Journal, vol. 8, no. 4, pp. 357- 376, 2017.
52. J. Karczewski, F. J. Troost, I. Konings et al., "Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier, " American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 298, no. 6, pp. G851-G859, 2010.
53. F. A. Carvalho, J. D. Aitken, M. Vijay-Kumar, and A. T. Gewirtz, "Toll-like receptor-gut microbiota interactions: Perturb at your own risk!, " Annual Review of Physiology, vol. 74, pp. 177-198, 2012.
54. Z. J. Liu, P. K. Yadav, J. L. Su, J. S. Wang, and K. Fei, "Potential role of Th17 cells in the pathogenesis of in flammatory bowel disease, " World Journal of Gastroenterology, vol. 15, no. 46, pp. 5784-5788, 2009.
55. Y. He, M. Gao, Y. Cao, H. Tang, S. Liu, and Y. Tao, "Nuclear localization of metabolic enzymes in immunity and metastasis, " Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol. 1868, no. 2, pp. 359-371, 2017.
56. W. Ren, S. Chen, L. Zhang et al., "Interferon tau affects mouse intestinal microbiota and expression of IL-17, " Mediators of Inflammation, vol. 2016, Article ID 2839232, 9 pages, 2016.
57. F. Aragón, S. Carino, G. Perdigón, and A. De Moreno de LeBlanc, "The administration of milk fermented by the probiotic Lactobacillus casei CRL 431 exerts an immunomodulatory effect against a breast tumour in a mouse model, " Immunobiology, vol. 219, no. 6, pp. 457-464, 2014.
58. J. Hu, C. Wang, L. Ye et al., "Anti-tumour immune effect of oral administration of Lactobacillus plantarum to CT26 tumourbearing mice, " Journal of Biosciences, vol. 40, no. 2, pp. 269-279, 2015.
59. I. Trabelsi, N. Ktari, S. Ben Slima, K. Hamden, and R. Ben Salah, "Effect of a probiotic Lactobacillus plantarum TN8 strain on trinitrobenzene sulphonic acid-induced colitis in rats, " Journal of Animal Physiology and Animal Nutrition, vol. 101, no. 2, pp. 311-319, 2017.
60. R. BenSalah, I. Trabelsi, R. BenMansour, S. Lassoued, H. Chouayekh, and S. Bejar, "A new Lactobacillus plantarum strain, TN8, from the gastro intestinal tract of poultry induces high cytokine production, " Anaerobe, vol. 18, no. 4, pp. 436-444, 2012.
61. E. K. Persson, C. L. Scott, A. M. Mowat, and W.W. Agace, "Dendritic cell subsets in the intestinal lamina propria: ontogeny and function, " European Journal of Immunology, vol. 43, no. 12, pp. 3098-3107, 2013.
62. L. Fu, J. Song, C. Wang, S. Fu, and Y. Wang, "Bifidobacterium infantis potentially alleviates shrimp tropomyosin-induced allergy by tolerogenic dendritic cell-dependent induction of regulatory T cells and alterations in gut microbiota, " Frontiers in Immunology, vol. 8, article no. 1536, 2017.
63. D. Srutkova, M. Schwarzer, T. Hudcovic et al., "Bifidobacterium longum CCM 7952 promotes epithelial barrier function and prevents acute dss-induced colitis in strictly strain-Specific manner, " PLoS ONE, vol. 10, no. 7, Article IDe0134050, 2015.
64. F. Turroni, E. Özcan, C. Milani et al., "Glycan cross-feeding activities between bifidobacteria under in vitro conditions, " Frontiers in Microbiology, vol. 6, Article ID01030, 2015.
65. B.O. Schroeder, G. M. H. Birchenough, M. Ståhlman et al., "Bifidobacteria or Fiber Protects against Diet-Induced Microbiota- Mediated Colonic Mucus Deterioration, " Cell Host & Microbe, 2017.
66. H. M. Savignac, M. Tramullas, B. Kiely, T. G. Dinan, and J. F. Cryan, "Bifidobacteria modulate cognitive processes in an anxious mouse strain, " Behavioural Brain Research, vol. 287, pp. 59- 72, 2015.
67. J. Arseneault-Bréard, I. Rondeau, K. Gilbert et al., "Combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 reduces post-myocardial infarction depression symptoms and restores intestinal permeability in a rat model, " British Journal of Nutrition, vol. 107, no. 12, pp. 1793-1799, 2012.
68. M. Schlee, J. Wehkamp, A. Altenhoefer, T. A. Oelschlaeger, E. F. Stange, and K. Fellermann, "Induction of human β-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin, " Infection and Immunity, vol. 75, no. 5, pp. 2399-2407, 2007.
69. G. Liu, W. Ren, J. Fang, and C. A. Hu, "L-Glutamine and L-arginine protect against enterotoxigenic Escherichia coli infection via intestinal innate immunity in mice, " Amino Acids, pp. 1-10, 2017.
70. A. A. Zyrek, C. Cichon, S. Helms, C. Enders, U. Sonnenborn, and M. A. Schmidt, "Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair, " Cellular Microbiology, vol. 9, no. 3, pp. 804-816, 2007.
71. M.-J. Fábrega, A. Rodríguez-Nogales, J. Garrido-Mesa et al., "Intestinal anti-inflammatory effects of outer membrane vesicles from Escherichia coli Nissle 1917 in DSS-experimental colitis in mice, " Frontiers inMicrobiology, vol. 8, article no. 1274, 2017.
72. M.-A. Cañas, R. Giménez, M.-J. Fábrega, L. Toloza, L. Baldomà, and J. Badia, "Outer membrane vesicles from the probiotic Escherichia coli Nissle 1917 and the commensal ECOR12 enter intestinal epithelial cells via clathrin-dependent endocytosis and elicit differential effects on DNA damage, " PLoS ONE, vol. 11, no. 8, Article ID e0160374, 2016.
73. E. Tarasova, E. Yermolenko, V. Donets et al., "The influence of probiotic Enterococcus faecium strain L5 on the microbiota and cytokines expression in rats with dysbiosis induced by antibiotics, " Beneficial Microbes, vol. 1, no. 3, pp. 265-270, 2010.
74. A. Fusco, V. Savio, M. Cammarota, A. Alfano, C. Schiraldi, and G. Donnarumma, "Beta-Defensin-2 and Beta-Defensin-3 reduce intestinal damage caused by Salmonella typhimurium modulating the expression of cytokines and enhancing the probiotic activity of enterococcus faecium, " Journal of Immunology Research, vol. 2017, 9 pages, 2017.
75. M. Li, L. Zhu, A. Xie, and J. Yuan, "Oral Administration of Saccharomyces boulardii Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats via Reducing Intestinal Permeability and ModulatingGutMicrobialComposition, " Inflammation, vol. 38, no. 1, pp. 170-179, 2014.
76. P. Brun et al., "Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS, " Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS, vol. 12, no. 7, Article ID e0181863, 2017.
77. G. S. Kopeina, V. V. Senichkin, and B. Zhivotovsky, "Caloric restriction - A promising anti-cancer approach: From molecular mechanisms to clinical trials, " Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol. 1867, no. 1, pp. 29-41, 2017.
78. A. Morandi and S. Indraccolo, "Linking metabolic reprogramming to therapy resistance in cancer, " Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol. 1868, no. 1, pp. 1-6, 2017.
79. W. Ren, P. Wang, J. Yan et al., "Melatonin alleviates weanling stress in mice: Involvement of intestinal microbiota, " Journal of Pineal Research, vol. 2, 2018.
80. J. Yin, W. Ren, X. Huang, T. Li, and Y. Yin, "Protein restriction and cancer, " Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol. 1869, no. 2, pp. 256-262, 2018.
81. J. Costa, "Glycoconjugates from extracellular vesicles: Structures, functions and emerging potential as cancer biomarkers, " Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol. 1868, no. 1, pp. 157-166, 2017.
82. G. Liu, S. Chen, G. Guan et al., "Chitosan Modulates Inflammatory Responses in Rats Infected with Enterotoxigenic Escherichia coli, " Mediators of Inflammation, vol. 2016, Article ID7432845, 6 pages, 2016.
83. J. Yin, H. Han, Y. Li et al., "Lysine Restriction Affects Feed Intake and Amino Acid Metabolism via Gut Microbiome in Piglets, " Cellular Physiology and Biochemistry, pp. 1749-1761, 2017.